Hepatic and haematological adverse reactions associated with the use of multidrug therapy in leprosy - A five year retrospective study

Indian Journal of Leprosy

Volumn 73, Issue 2, 2001, Pages 121-129

  Kaluarachchi, S I ^a   Fernandopulle, B M R ^a   Gunawardane, B P ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; ETHIONAMIDE; RIFAMPICIN;

ADOLESCENT; ADULT; AGE; AGED; ANEMIA; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HUMAN; LEPROSY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METHEMOGLOBINEMIA; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SRI LANKA; TOXIC HEPATITIS; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ANEMIA; CHILD; CLOFAZIMINE; DAPSONE; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS, TOXIC; HUMANS; LEPROSTATIC AGENTS; LEPROSY; MALE; METHEMOGLOBINEMIA; MIDDLE AGED; RETROSPECTIVE STUDIES; RIFAMPIN;

EID: 0034848064     PISSN: 02549395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Report of an international consensus meeting: Criteria of drug-induced liver disorders
2. Results of a surveillance system for adverse effects in leprosy
3. Effect of dapsone on haemoglobin concentration in patients with leprosy
4. Dapsone syndrome in a Filipino man
5. Dapsone syndrome - A five year retrospective analysis
6. Drugs used in tuberculosis and leprosy
7. A look at world leprosy
8. Influence of acetylator phenotype on the haemotological and biochemical effects associated with dapsone in leprosy patients
9. Chemotherapy of leprosy for control programmes - Report of a WHO Study Group
10. Glucose-6-phosphate dehydrogenase deficiency
11. Drugs used in leprosy
12. The impact of multidrug therapy on leprosy disabilities